Loading…
Dividends declared (per SOCE filings): FY2016 0 · FY2017 0 · FY2018 0 — 3-yr total 0
Medimex is a Georgian pharmaceutical wholesale and distribution company.
Group parent — controls 1 company · ownership
| Line item | 2017 | 2018 | CAGR |
|---|---|---|---|
| Total Revenue | 2,002 | 1,299 | -35.1% |
| Total COGS | 639 | 719 | +12.6% |
| Gross Profit | 1,363 | 580 | -57.4% |
| Gross Margin | 68.1% | 44.7% | |
| 214 | 110 | -48.6% | |
| EBITDA | 1,150 | 470 | -59.1% |
| EBITDA Margin | 57.4% | 36.2% | |
| Total D&A | 14 | 21 | +46.6% |
| EBIT / Operating Income | 1,136 | 450 | -60.4% |
| Total Interest Income | 12 | 534 | +4541.3% |
| Total Interest Expense | 951 | 0 | nmf |
| 224 | 8,040 | nmf | |
| Profit Before Tax | 28 | 9,023 | nmf |
| Total Income Tax | 0 | 0 | |
| Net Profit / (Loss) | 580 | 8,771 | nmf |
| Net Margin | 28.9% | 675.1% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →